Austin Walters
Co-Founder, Managing Partner, Investment Committee Member @ SpringTide Ventures
Cambridge, United States
Austin Walters is a seed investor at SpringTide Ventures in Cambridge focused on Health Care and Medical. Austin Walters is the Founder and Managing Partner at SpringTide. He attended Harvard Business School.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Austin Walters invests in
Stages Austin Walters invests in
Countries Austin Walters invests in
Investment Focus
Industry
- Health Care 14 (48%)
- Medical 8 (28%)
- Medical Device 4 (14%)
- Software 3 (10%)
- Biotechnology 3 (10%)
Stage
- Seed 11 (38%)
- Series A 6 (21%)
- Funding Round 5 (17%)
- Series B 1 (3%)
- Series C 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dopl Technologies
|
Dopl Technologies develops remote robotic ultrasound systems that combine robotics, telepresence, and AI to expand access to diagnostic imaging. Its platform enables healthcare providers to perform ultrasound examinations remotely, helping hospitals and clinics address workforce shortages and improve access to imaging services. The company focuseson diagnostic imaging solutions for rural and underserved healthcare settings. | $6.3M / Seed / Jul 27, 2026 | |
Tava Health
|
Tava Health provides digital mental health services that connect individuals with licensed therapists through an online platform. The company offers therapy sessions via video, along with tools for scheduling, communication, and care coordination. Its services are structured to support employers and organizations in delivering mental healthbenefits to their members or employees. The platform includes features for matching users with therapists based on preferences and clinical needs. Tava Health also provides administrative support and reporting tools to help organizations manage utilization and access to care. | $40M / Series C / Apr 21, 2026 | |
Biotia
|
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes. | $8M / Series A / Aug 23, 2022 | |
Marigold Health
|
Marigold Health uses AI-augmented chat support groups to reach and retain patients with behavioral health needs in community-based treatment. Patients receive a personalized wraparound support while care teams see dramatic gains in capacity using patients to engage each other. We partner directly with treatment providers and managed careorganizations in the Medicaid market. | $6M / Seed / Feb 01, 2022 | |
Prolucent Health
|
Prolucent Health provides technology and services that empower modern workforce management. | $11.5M / Series A / Dec 13, 2021 | |
|
Prolucent Health
|
Prolucent Health provides technology and services that empower modern workforce management. | $11.5M / Series A / Dec 13, 2021 | |
|
Tava Health
|
Tava Health provides digital mental health services that connect individuals with licensed therapists through an online platform. The company offers therapy sessions via video, along with tools for scheduling, communication, and care coordination. Its services are structured to support employers and organizations in delivering mental healthbenefits to their members or employees. The platform includes features for matching users with therapists based on preferences and clinical needs. Tava Health also provides administrative support and reporting tools to help organizations manage utilization and access to care. | $10M / Series A / Dec 09, 2021 | |
Pathology Watch
|
Pathology Watch delivers an intuitive and easy-to-implement digital pathology solution for dermatologists. They work with clinical dermatology practices to digitize the pathology workflow, which is helping to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. They also deliveran intuitive and easy-to-implement digital pathology solution that includes access to top-tier Dermatopathologists.It was founded in 2017 and is based in Salt Lake City, Utah. | $25M / Series B / Nov 16, 2021 | |
|
Marigold Health
|
Marigold Health uses AI-augmented chat support groups to reach and retain patients with behavioral health needs in community-based treatment. Patients receive a personalized wraparound support while care teams see dramatic gains in capacity using patients to engage each other. We partner directly with treatment providers and managed careorganizations in the Medicaid market. | $2M / Sep 10, 2021 | |
|
Marigold Health
|
Marigold Health uses AI-augmented chat support groups to reach and retain patients with behavioral health needs in community-based treatment. Patients receive a personalized wraparound support while care teams see dramatic gains in capacity using patients to engage each other. We partner directly with treatment providers and managed careorganizations in the Medicaid market. | $2M / Seed / Sep 10, 2021 | |
| See all 29 investments → | |||
Co-Investors
About SpringTide Ventures
SpringTide is a venture capital that provides investment in the health tech industry. The firm was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.
SpringTide Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Austin Walters
Co-Founder, Managing Partner, Investment Committee Member
|
|||
Brad Otto
Principal
|
|||
Andrea Paul
Venture Partner
|
|||
Daniel Lambert
Co-Founder, Investment Committee Member
|
|||
Daniel Lambert
Co-Founder, Investment Committee Member
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Austin Walters invest in?
Austin Walters invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Series A stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Austin Walters last invest?
The most recent investment recorded for Austin Walters closed in Jul 2026. Shizune tracks 29 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
